In our study, we found that RESV, when used alone, promoted the accumulation of cells in the G0/G1 phase and S or G2/M phase depending on the lung cancer cell lines, with the most significant arrest in G2/M phase for HCC827 cell line, which is the representative of EGFR-mutant lung cancer. Here, EGFR is linked to lung carcinoma.